Literature DB >> 9265748

Manganese metabolism is impaired in the Belgrade laboratory rat.

A C Chua1, E H Morgan.   

Abstract

Homozygous Belgrade rats have a hypochromic anaemia due to impaired iron transport across the cell membrane of immature erythroid cells. This study aimed at investigating whether there are also abnormalities of Mn metabolism in erythroid and other types of cells. The experiments were performed with homozygous (b/b) and heterozygous (+/b) Belgrade rats and Wistar rats and included measurements of Mn uptake by reticulocytes in vitro, Mn absorption from in situ closed loops of the duodenum, and plasma clearance and uptake by several organs after intravenous injection of radioactive Mn bound to transferrin (Tf) or mixed with serum. Similar measurements were made with 59Fe-labelled Fe in several of the experiments. Mn uptake by reticulocytes and absorption from the duodenum was impaired in b/b rats compared with +/b or Wistar rats. The plasma clearance of Mn-Tf was much slower than Mn-serum, but both were faster than the clearance of Fe-Tf. Uptake of 54Mn by the kidneys, brain and femurs was less in b/b than Wistar or /+b rats, but uptake by the liver was greater in b/n rats. Similar differences were found for 59Fe uptake by kidneys, brain and femurs but is concluded that the genetic abnormality present in b/b rats affects Mn metabolism as well as Fe metabolism and that Mn and Fe share similar transport mechanisms in the cells of erythroid tissue, duodenal mucosa, kidney and blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9265748     DOI: 10.1007/s003600050085

Source DB:  PubMed          Journal:  J Comp Physiol B        ISSN: 0174-1578            Impact factor:   2.200


  42 in total

1.  Olfactory uptake of manganese requires DMT1 and is enhanced by anemia.

Authors:  Khristy Thompson; Ramon M Molina; Thomas Donaghey; James E Schwob; Joseph D Brain; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2006-11-20       Impact factor: 5.191

Review 2.  Physiologic implications of metal-ion transport by ZIP14 and ZIP8.

Authors:  Supak Jenkitkasemwong; Chia-Yu Wang; Bryan Mackenzie; Mitchell D Knutson
Journal:  Biometals       Date:  2012-02-09       Impact factor: 2.949

3.  Effects of iron status on transpulmonary transport and tissue distribution of Mn and Fe.

Authors:  Joseph D Brain; Elizabeth Heilig; Thomas C Donaghey; Mitchell D Knutson; Marianne Wessling-Resnick; Ramon M Molina
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-09       Impact factor: 6.914

4.  Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport.

Authors:  M D Fleming; M A Romano; M A Su; L M Garrick; M D Garrick; N C Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Ferroportin deficiency impairs manganese metabolism in flatiron mice.

Authors:  Young Ah Seo; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2015-03-17       Impact factor: 5.191

6.  Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.

Authors:  Zhaobao Yin; Haiyan Jiang; Eun-Sook Y Lee; Mingwei Ni; Keith M Erikson; Dejan Milatovic; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2009-12-09       Impact factor: 5.372

7.  Hepatic uptake and biliary excretion of manganese in the little skate, Leucoraja erinacea.

Authors:  Michael S Madejczyk; James L Boyer; Nazzareno Ballatori
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-12-24       Impact factor: 3.228

Review 8.  Manganese transport in eukaryotes: the role of DMT1.

Authors:  Catherine Au; Alexandre Benedetto; Michael Aschner
Journal:  Neurotoxicology       Date:  2008-05-14       Impact factor: 4.294

Review 9.  Manganese flux across the blood-brain barrier.

Authors:  Robert A Yokel
Journal:  Neuromolecular Med       Date:  2009-11-10       Impact factor: 3.843

Review 10.  Brain barrier systems: a new frontier in metal neurotoxicological research.

Authors:  Wei Zheng; Michael Aschner; Jean-Francois Ghersi-Egea
Journal:  Toxicol Appl Pharmacol       Date:  2003-10-01       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.